HEPTARES
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 02 Jan 2024)
What this means for you
Registered since 11 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86577541
- Registration number
- 5239010
- Mark type
- Stylized text
- Filed
- 26 Mar 2015
- Published for opposition
- 25 Apr 2017
- Registered
- 11 Jul 2017
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: [ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
- Class 005 — Pharmaceuticals: [ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
- Class 042 — Scientific and technological services: Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
Owner
- NXERA PHARMA CO., LTD, TOKYO, JP
- SOSEI GROUP CORPORATION, TOKYO, JP
- Heptares Therapeutics Limited, Cambridge, GB
- Heptares Therapeutics Limited, Hertfordshire, GB
- Heptares Therapeutics Limited, Hertfordshire, GB
Prosecution history
- 04 Jul 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Jan 2024 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 11 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 May 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Oct 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Oct 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Apr 2017 — PUBLISHED FOR OPPOSITION
- 05 Apr 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 10 Mar 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER